Healthcare -
Biotechnology - NASDAQ - US
$ 2.4
-2.44 %
$ 128 M
Market Cap
-2.53
P/E
TCRX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities TCRX - TScan Therapeutics, Inc.
-60.8 M
LAST VALUE
-147.22%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR